Optimizing Treatment for Children in the Developing World

✍ Scribed by Stuart MacLeod, Suzanne Hill, Gideon Koren, Anders Rane (eds.)

• Publisher: ADIS
• Year: 2015
• Tongue: English
• Leaves: 333
• Edition: 1
• Category: Library

✦ Synopsis

This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.

✦ Table of Contents

Front Matter....Pages i-xvii
Front Matter....Pages 1-1
Children Everywhere Deserve Evidence-Based and Accessible Treatment....Pages 3-11
Shifting Demographics and Clinical Pharmacy/Pharmacology Priorities....Pages 13-19
Access to Medicines – More Than Just Affordability....Pages 21-32
Challenges in Pediatric Oral Dosing....Pages 33-44
Therapeutic Research in Low-Income Countries: Studying Trial Communities....Pages 45-52
MicroResearch: Finding Sustainable Local Health Solutions in East Africa Through Small Local Research Studies....Pages 53-64
Medications in Pregnancy: Can We Treat the Mother While Protecting the Unborn?....Pages 65-70
Drugs and Breastfeeding: The Knowledge Gap....Pages 71-79
Falsified and Substandard Medicines....Pages 81-95
Front Matter....Pages 97-97
Regulatory Science for Paediatric Medicines in Low- and Middle-Income Countries....Pages 99-108
Enabling Equitable Access to Essential Medicines....Pages 109-116
Clinical Pharmacy and Pharmaceutical Care....Pages 117-125
Promoting Drug Development and Access: The Role of International Networks and Organizations....Pages 127-139
Front Matter....Pages 141-141
Standards of Research for Clinical Trials in Low- and Middle-Income Countries....Pages 143-158
Ethical Considerations in the Design of Pediatric Clinical Trials in Low- and Middle-Income Countries....Pages 159-174
Micronutrient Deficiencies: Impact on Therapeutic Outcomes....Pages 175-186
Clinical Pharmacology and the Individualized Approach to Treatment....Pages 187-201
Neglected Diseases: Drug Development for Chagas Disease as an Example....Pages 203-211
Health Economic Evaluation for Improving Child Health in Low- and Middle-Income Countries....Pages 213-224
Rational Use of Medicines (RUM) for Children in the Developing World: Current Status, Key Challenges and Potential Solutions....Pages 225-238
Front Matter....Pages 141-141
Perspective on the Role of the Pharmaceutical Industry....Pages 239-247
Front Matter....Pages 249-249
Optimizing Malaria Treatment in the Community....Pages 251-264
Critical Care for Children in Low- and Middle-Income Countries: Issues Barriers and Opportunities....Pages 265-278
Child and Adolescent Mental Health Disorders: Organization and Delivery of Care....Pages 279-289
Psychotropic Medications in Pregnancy....Pages 291-302
Child Development, Disability and Global Health: Opportunity and Responsibility....Pages 303-310
Hydroxyurea Therapy for Sickle Cell Disease in Low-Income Countries....Pages 311-318
Front Matter....Pages 319-319
Challenges in Drug Therapy of Children in Africa....Pages 321-323
Training Clinicians in Developing Countries on Rational Use of Medications in Children and Pregnant Women....Pages 325-327
Taking Medicines for Children Forward....Pages 329-332

✦ Subjects

Pediatrics; General Practice / Family Medicine; Pharmacotherapy